rs765451128
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000517.6(HBA2):c.*46C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,456,468 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000517.6 3_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1456468Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 724400
GnomAD4 genome Cov.: 25
ClinVar
Submissions by phenotype
not provided Uncertain:1
The HBA2 c.*46C>A variant (also known as +46C>A) has been described to be associated with alpha(+) thalassemia (ITHANET (http://www.ithanet.eu/)). This variant has been reported in the heterozygous state in an individual with anemia (PMID: 19373587 (2009)). It has also been reported to occur in the -alpha3.7 fusion gene with symptoms ranging from mild microcytic anemia (PMID 25370869 (2014), 24018802 (2013)) to HbH disease (PMID 23668236 (2013)). This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). Based on the available information, we are unable to determine the clinical significance of this variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at